ADVERTISEMENT

Stem cell transplant bests drug therapy for secondary progressive multiple sclerosis

Susan London   |   Clinical Summary   |   30 December 2022
ADVERTISEMENT

Autologous haematopoietic stem cell transplantation was superior to disease-modifying medications for slowing disability progression.

Takeaway

  • Compared with disease-modifying therapies (DMTs), autologous haematopoietic stem cell transplantation halved the risk for confirmed disability progression in patients with clinically active secondary progressive multiple sclerosis.

Why this matters

  • Available DMTs have little effect on disability...

          

Topic Challenges

left
right